Earnest Partners LLC Novartis Ag Transaction History

Earnest Partners LLC

  • $20.7 Billion
  • Q2 2024

A detailed history of Earnest Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Earnest Partners LLC holds 809,287 shares of NVS stock, worth $89.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
809,287
Previous 835,551 3.14%
Holding current value
$89.5 Million
Previous $80.8 Million 6.6%
% of portfolio
0.42%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $2.43 Million - $2.82 Million
-26,264 Reduced 3.14%
809,287 $86.2 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $2.05 Million - $2.34 Million
21,535 Added 2.65%
835,551 $80.8 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $168,115 - $185,005
-1,822 Reduced 0.22%
814,016 $82.2 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $2.29 Million - $2.54 Million
-24,170 Reduced 2.88%
815,838 $83.1 Million
Q2 2023

Aug 07, 2023
SELL
$92.52 - $104.91 $994,960 - $1.13 Million
-10,754 Reduced 1.26%
840,008 $84.8 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $505,389 - $586,095
-6,315 Reduced 0.74%
850,762 $78.3 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $1.11 Million - $1.35 Million
-14,641 Reduced 1.68%
857,077 $77.8 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $356,934 - $417,451
4,784 Added 0.55%
871,718 $66.3 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $2.14 Million - $2.49 Million
-26,592 Reduced 2.98%
866,934 $73.3 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $904,602 - $1.02 Million
-11,292 Reduced 1.25%
893,526 $78.4 Million
Q4 2021

Feb 07, 2022
SELL
$79.7 - $88.13 $2.98 Million - $3.3 Million
-37,394 Reduced 3.97%
904,818 $79.1 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $4.34 Million - $5.05 Million
-53,037 Reduced 5.33%
942,212 $77.1 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $6.57 Million - $7.26 Million
-77,132 Reduced 7.19%
995,249 $90.8 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $6.65 Million - $7.84 Million
79,658 Added 8.02%
1,072,381 $91.7 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $1.61 Million - $1.95 Million
20,661 Added 2.13%
992,723 $93.7 Million
Q3 2020

Nov 16, 2020
SELL
$82.14 - $91.0 $1.52 Million - $1.69 Million
-18,518 Reduced 1.87%
972,062 $84.5 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $27.7 Million - $31.2 Million
-342,241 Reduced 25.68%
990,580 $86.5 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $40.2 Million - $56.4 Million
-569,158 Reduced 29.92%
1,332,821 $110 Million
Q4 2019

Feb 07, 2020
SELL
$84.35 - $95.37 $3.23 Million - $3.65 Million
-38,288 Reduced 1.97%
1,901,979 $180 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $964,976 - $1.06 Million
11,281 Added 0.58%
1,940,267 $169 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $1.55 Million - $1.91 Million
-20,544 Reduced 1.05%
1,928,986 $176 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $1.9 Million - $2.18 Million
25,274 Added 1.31%
1,949,530 $187 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $1.97 Million - $2.19 Million
-26,699 Reduced 1.37%
1,924,256 $165 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $1.53 Million - $1.77 Million
-22,795 Reduced 1.15%
1,950,955 $168 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $214,267 - $242,161
3,301 Added 0.17%
1,973,750 $149 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $1.92 Million - $2.3 Million
-27,339 Reduced 1.37%
1,970,449 $159 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $613,286 - $658,309
-8,479 Reduced 0.42%
1,997,788 $168 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $3.25 Million - $3.38 Million
-43,791 Reduced 2.14%
2,006,267 $172 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,050,058
2,050,058 $171 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Earnest Partners LLC Portfolio

Follow Earnest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email